These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9202641)

  • 1. Functional and histological differences in autogenous and allogenic vein grafts: two different vasculopathies?
    Davies MG; Dalen H; Svendsen E; Hagen PO
    J Surg Res; 1997 Apr; 69(1):14-22. PubMed ID: 9202641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
    Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
    Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling transplant vasculopathy in cryopreserved vein grafts with polyethylene glycol and glutathione during transport.
    Davies MG; Huynh TT; Fulton GJ; Svendsen E; Brockbank FG; Hagen PO
    Eur J Vasc Endovasc Surg; 1999 Jun; 17(6):493-500. PubMed ID: 10375485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
    Davies MG; Huynh TT; Hagen PO
    J Surg Res; 2000 Jul; 92(1):103-7. PubMed ID: 10864489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential response of arteries and vein grafts to blood flow reduction.
    Galt SW; Zwolak RM; Wagner RJ; Gilbertson JJ
    J Vasc Surg; 1993 Mar; 17(3):563-70. PubMed ID: 8445753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of intimal hyperplasia with restoration of endothelium-dependent relaxing factor-mediated relaxation in experimental vein grafts.
    Davies MG; Klyachkin ML; Dalen H; Svendsen E; Hagen PO
    Surgery; 1993 Aug; 114(2):258-70; discussion 270-1. PubMed ID: 8342130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts.
    Huynh TT; Iaccarino G; Davies MG; Svendsen E; Koch WJ; Hagen PO
    Surgery; 1998 Aug; 124(2):177-86. PubMed ID: 9706136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
    Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
    J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of perioperative catheter injury on the long-term vein graft function and morphology.
    Davies MG; Dalen H; Svendsen E; Hagen PO
    J Surg Res; 1996 Dec; 66(2):109-14. PubMed ID: 9024820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional and morphological consequences of balloon catheter injury in veins.
    Davies MG; Dalen H; Svendsen E; Hagen PO
    J Surg Res; 1994 Jul; 57(1):122-32. PubMed ID: 8041126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The temporal sequence of G-protein expression in intimal hyperplasia.
    Davies MG; Barber L; Dhanraj DN; Gettys TW; Ramkumar V; Hagen PO
    J Surg Res; 1996 Jun; 63(1):115-22. PubMed ID: 8661183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft.
    Maekawa T; Komori K; Morisaki K; Itoh T
    J Vasc Surg; 2012 Dec; 56(6):1689-97. PubMed ID: 22857809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of perioperative storage solutions on long-term vein graft function and morphology.
    Davies MG; Hagen PO
    Ann Vasc Surg; 1994 Mar; 8(2):150-7. PubMed ID: 8198948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.
    Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1995 Jul; 59(1):35-42. PubMed ID: 7630134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
    Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
    J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. University of Wisconsin solution effects on intimal proliferation in canine autogenous vein grafts.
    Cavallari N; Abebe W; Hunter WJ; Agrawal DK; Sapienza P; Mingoli A; Cavallaro A; Edwards JD
    J Surg Res; 1995 Oct; 59(4):433-40. PubMed ID: 7564313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
    J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.